U.S. Stock News

NasdaqGS:HQY
NasdaqGS:HQYHealthcare

How HealthEquity’s GARP Profile and Accelerating Earnings Narrative At HealthEquity (HQY) Has Changed Its Investment Story

Recently published analyst research highlighted HealthEquity as a leading provider of technology-enabled healthcare spending solutions with solid growth characteristics and financial strength, operating in a market supported by structural tailwinds. What stands out is HealthEquity’s identification as a Growth at a Reasonable Price candidate, where accelerating earnings trends intersect with valuation metrics that appear attractive relative to peers. We’ll now examine how HealthEquity’s GARP...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Is It Time To Reassess Fifth Third Bancorp (FITB) After Its Recent Share Price Strength

If you are wondering whether Fifth Third Bancorp at around US$50.22 is still reasonably priced or starting to look stretched, you are not alone. The stock has seen a 1% decline over the last 7 days, while its 30 day return stands at 7.3% and its 1 year return at 17.5%, with longer term figures of 50.7% over 3 years and 88.4% over 5 years. These moves come against a backdrop of ongoing sector wide attention on U.S. regional banks, with investors watching how balance sheets, capital levels and...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

How Investors Are Reacting To OceanFirst Financial (OCFC) Earnings: Loan Growth, Cost Pressures And Steady Dividend

OceanFirst Financial Corp. reported fourth-quarter 2025 results on January 22, 2026, with net interest income rising to US$95.28 million but net income easing to US$13.09 million, alongside net loan charge-offs of US$1.97 million and a continued quarterly dividend of US$0.20 per share. The earnings release highlighted that strong commercial and industrial loan and deposit growth came with higher merger- and outsourcing-related expenses, compressing profitability even as the board declared...
NYSE:CYD
NYSE:CYDMachinery

China Yuchai International (CYD) Valuation Check After Strong Share Price Momentum

China Yuchai International: Recent Move Puts Engine Maker on Investor Radar China Yuchai International (CYD) has drawn fresh attention after a strong month, with the share price rising about 28% and a gain of roughly 22% over the past 3 months. See our latest analysis for China Yuchai International. The recent 30 day share price return of 27.83% and 90 day share price return of 22.38% sit alongside a very large 1 year total shareholder return of 324.08%. This points to strong positive...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Is It Too Late To Consider Medpace (MEDP) After Its Strong Multi Year Share Price Run

If you are wondering whether Medpace Holdings is still good value after its strong run, you are not alone. This article focuses squarely on what you are paying for each dollar of its business today. The stock last closed at US$582.48, with returns of 3.7% over the past 30 days, 2.0% year to date, 66.8% over 1 year and 146.7% over 3 years. These figures naturally raise questions about how much future upside or risk is already reflected in the price. Recent news around Medpace has largely...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Is Virgin Galactic (SPCE) Pricing In Too Much Pessimism After Its 40% One-Year Slide

Wondering whether Virgin Galactic Holdings at US$2.85 is a bargain or a value trap? This article walks through what the current price may be implying about the stock. The share price has seen steep declines, with returns of 7.2% over 7 days, 11.2% over 30 days, 13.4% year to date and 40.1% over 1 year, and an even larger 3 year and 5 year pullback of 97.7% and 99.7% respectively. These moves sit against a backdrop of ongoing attention on the commercial space tourism theme, including frequent...
NYSE:SYK
NYSE:SYKMedical Equipment

Is It Too Late To Consider Stryker (SYK) After Recent Valuation Checks?

If you are wondering whether Stryker shares are offering good value right now, it helps to separate the story from the numbers we can actually measure. The stock last closed at US$369.56, with returns of 4.1% over 7 days, 5.1% over 30 days, 6.1% year to date, 34.4% over 3 years and 63.0% over 5 years, while the 1 year return sits at a 4.7% decline. Recent headlines around Stryker have kept investor attention on how the company is positioned in the medical technology and healthcare space, and...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

SoFi Technologies Q3 Net Margin Expansion Reinforces Bullish Profitability Narratives

SoFi Technologies FY 2025 earnings snapshot SoFi Technologies (SOFI) has put up another solid set of numbers for FY 2025 so far, with Q3 revenue at US$952.4 million and basic EPS of US$0.12, backed by trailing twelve month net income of US$640.2 million and EPS of US$0.57. The company has seen revenue move from US$586.9 million in Q2 2024 to US$952.4 million in Q3 2025, while quarterly basic EPS has gone from US$0.01 to US$0.12 over the same stretch. This sets the stage for investors to focus...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

QuidelOrtho Faces Profitability Pressures Yet Trades At Steep Valuation Discount

QuidelOrtho (NasdaqGS:QDEL) is reporting declining revenues alongside falling free cash flow margins. The company is also seeing a significant drop in return on invested capital, pointing to weaker returns on recent investments. These shifts may reflect rising competitive pressures or market saturation in its core diagnostics markets. QuidelOrtho, a diagnostics company listed on the NasdaqGS under ticker QDEL, operates across lab, point of care, and transfusion medicine testing. The current...
NYSE:PFSI
NYSE:PFSIDiversified Financial

PennyMac Financial Services (PFSI) Net Margin Expansion Reinforces Bullish Profitability Narratives

PennyMac Financial Services (PFSI) has wrapped up FY 2025 with fourth quarter revenue of US$538.0 million, basic EPS of US$2.05 and net income of US$106.8 million, while the trailing twelve months show total revenue of US$2.0 billion, basic EPS of US$9.69 and net income of US$501.1 million against last year’s net margin of 15.4% and earnings growth of 60.9%. Over the past few quarters, revenue has ranged from US$690.8 million to US$1.0 billion with quarterly basic EPS between US$1.48 and...
NYSE:APD
NYSE:APDChemicals

Is It Time To Reassess Air Products And Chemicals (APD) After Recent Share Price Rebound

If you are wondering whether Air Products and Chemicals is genuinely attractive at its current price, you are not alone. Many investors are asking if the stock still offers value after recent moves. The share price closed at US$272.50, with returns of 4.3% over the last week, 10.3% over the last month, 8.8% year to date, a 16.6% decline over the past year, 3.3% gains over three years and 21.8% gains over five years. Recent coverage around Air Products and Chemicals has focused on its...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Carlos Vazquez Joins Valley National Board Sharpening Risk And Capital Oversight

Valley National Bancorp (NasdaqGS:VLY) has appointed veteran banking executive Carlos Vazquez as an independent director. Vazquez brings decades of C suite and board experience at major financial institutions to Valley's board. He will serve on key committees focused on financial oversight, audit, and human capital governance. For you as an investor, this move sits squarely in the context of a regional bank sector that is under close scrutiny on risk management, funding stability, and board...
NasdaqCM:GEVO
NasdaqCM:GEVOOil and Gas

Assessing Gevo (GEVO) Valuation After CEO Succession Plan And Carbon Removal Progress

Leadership transition and carbon-removal update draw focus Gevo (GEVO) has attracted fresh attention after a special call outlining its planned CEO succession to President Paul Bloom in 2026 and providing updates on carbon-removal progress, including 500,000 credits from its North Dakota project. See our latest analysis for Gevo. Gevo’s recent leadership update and carbon removal progress come against a backdrop of softer share price momentum, with a 7 day share price return of 10.5% and a 90...
NYSE:PJT
NYSE:PJTCapital Markets

PJT Partners Sees 2026 Secondaries Surge Shaping Capital Solutions Opportunity

PJT Partners (NYSE:PJT) has forecast continued robust growth in global secondaries market volume for 2026. The outlook follows what the firm describes as a record year for secondaries activity. PJT's global head of Capital Solutions outlined the view, highlighting potential large scale shifts in capital flows. PJT Partners, trading at $173.03, sits in the spotlight as the firm links its capital solutions franchise to a secondaries market it expects to stay busy into 2026. The stock has...
NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders

Sanofi agreed to acquire Dynavax Technologies (NasdaqGS:DVAX) in a multi billion dollar deal. The transaction focuses on adding Dynavax's approved hepatitis B vaccine and its experimental shingles vaccine to Sanofi's adult vaccines portfolio. The deal is framed as an expansion of Sanofi's presence in adult immunizations. Dynavax Technologies, known for its vaccine work including its hepatitis B product, sits at the intersection of adult immunization and broader infectious disease...
NYSE:ESRT
NYSE:ESRTOffice REITs

Is Empire State Realty Trust (ESRT) Pricing Reflect Long-Term Prospects After Office And Tourism Shifts

If you are wondering whether Empire State Realty Trust's share price still reflects the value of its assets and income potential, looking closely at how the market currently prices the stock is a useful next step. The shares last closed at US$6.63, and over recent periods the stock saw a 1% decline over 7 days, a 1.7% gain over 30 days, a 2.5% gain year to date, but a 29.4% decline over 1 year and a 27.1% decline over 5 years. Recent price moves sit against an ongoing news flow around Empire...
NYSE:ACA
NYSE:ACAConstruction

Will Stronger Earnings And Upbeat Analyst Ratings Change Arcosa's (ACA) Narrative?

Recently, Barclays analyst Adam Seiden and TipRanks reiterated positive ratings on Arcosa following the company’s latest earnings release, which reported meaningful year-over-year revenue and net profit growth. This combination of upbeat analyst sentiment and improved financial performance has drawn fresh attention to how Arcosa is executing its business plan. We’ll now look at how Arcosa’s stronger earnings profile may influence the company’s investment narrative and longer-term appeal. AI...
NYSE:FTI
NYSE:FTIEnergy Services

Is It Too Late To Consider TechnipFMC (FTI) After Its 86% One-Year Rally?

If you are wondering whether TechnipFMC at around US$55.72 is still offering value or if most of the upside is already reflected in the price, you are asking the right question. The stock has delivered returns of 2.7% over the last 7 days, 25.0% over the last 30 days, 17.8% year to date and 86.5% over the last year, with a very large 3 year and 5 year return. This naturally raises questions about what you are paying for today. Recent coverage has focused on TechnipFMC's role in the energy...
NasdaqCM:NEGG
NasdaqCM:NEGGSpecialty Retail

A Look At Newegg Commerce (NEGG) Valuation After Chairman Detention And Governance Concerns

Newegg Commerce (NEGG) is back in focus after the company disclosed that chairman and controlling shareholder He Zhitao has been detained and placed under investigation, with multiple law firms now reviewing potential securities law issues. See our latest analysis for Newegg Commerce. The governance shock around the chairman’s detention comes after a sharp 41.6% decline in the 90 day share price return and a 10.8% fall over the last day, even though the 1 year total shareholder return remains...
NYSE:SPH
NYSE:SPHGas Utilities

Suburban Propane Elevates Dagan To Guide Renewables And Long Term Growth

Suburban Propane Partners (NYSE:SPH) has created a new Senior Vice President, Renewable Energy role. M. Douglas Dagan has been promoted to fill this position, with responsibility for the partnership's renewable energy efforts. Suburban Propane Partners, trading at around $20.17, is best known for its propane distribution business, and its recent returns show meaningful longer term share price movement. The units are up 3.8% over the past week, 8.8% over the past 30 days, 7.9% year to date,...
NYSE:VZ
NYSE:VZTelecom

Verizon Communications (VZ) Margin Surge To 14.4% Tests Bearish Profitability Narratives

Verizon Communications (VZ) just posted its FY 2025 third quarter numbers, with revenue at US$33.8b, basic EPS of US$1.17 and net income excluding extra items of US$4.9b. The company has seen quarterly revenue move from US$33.3b in Q3 2024 to US$33.8b in Q3 2025, while basic EPS over the same quarters went from US$0.78 to US$1.17. This gives investors a clear read on how the top line and EPS have tracked over the past year. With trailing 12 month net profit margin reported at 14.4% versus...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Why Sandisk (SNDK) Is Up 21.6% After AI-Driven Beat And Extended Kioxia Capacity Pact

In late January 2026, Sandisk reported past second-quarter results showing sharply higher sales and profits and issued upbeat third-quarter revenue guidance, citing intense AI-driven demand for its NAND flash and enterprise SSD products. On the same day, Kioxia Corporation and Sandisk announced they had extended their long-running Yokkaichi and Kitakami flash-memory joint venture agreements through 2034, with Sandisk committing US$1.17 billion in staged payments to secure long-term...
NasdaqGS:OZK
NasdaqGS:OZKBanks

How Investors May Respond To Bank OZK (OZK) After Boston CRE Write-Off Amid Higher Interest Income

In January 2026, Bank OZK reported fourth-quarter 2025 results showing higher net interest income of US$407.05 million but slightly lower net income of US$175.96 million, alongside a US$72 million write-off on a vacant East Cambridge commercial property. This write-off underscores Bank OZK’s meaningful exposure to commercial real estate, particularly in the Boston market, where it has about US$1.40 billion in active loans. With recent results highlighting the US$72 million commercial real...
NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

Is InMode (INMD) Priced Attractive After Recent 7% Monthly Share Price Gain

Wondering if InMode at around US$15.71 is a bargain or a value trap? This article will walk you through what the current price might be implying. The stock has returned 12.6% over the last 7 days and 6.9% over the last 30 days, although the 1 year return of 8.7% and 3 year return of 57.8% show a very different experience for longer term holders. That mix of shorter term gains and weaker multi year returns has kept attention on how the market is reassessing InMode, with many investors...